Skip to main content

Registry-Based Stroke Research

  • Chapter
  • First Online:
Precision Medicine in Stroke

Abstract

By definition ‘registry’ is a place where official names and/or items are kept forming an official list or register. Patient registry is an organized system to collect data that uses observational study methods. A patient registry often collects demographic, risk factors, treatments, outcomes and other clinical data to evaluate specified characteristics, management, follow-up, benchmarking or outcomes for a defined population by a particular disease, condition or exposure. Patient registries are usually created by researchers, research institutions, academic clinical institutions or individual research teams. Registries can generate large amounts of data in a short time.

In this chapter we focus on clinical registries and discuss the various types of registry-based studies and their strengths and limitations compared to randomized studies. Finally, we give some examples of national stroke registries and a large international stroke registry and discuss its strengths and limitations along with its achievements.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gail MH, Altman DG, Cadarette SM, et al. Design choices for observational studies of the effect of exposure on disease incidence. BMJ Open. 2019;9:e031031. https://doi.org/10.1136/bmjopen-2019-031031.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Workman TA. Engaging patients in information sharing and data collection: the role of patient-powered registries and research networks. Rockville, MD: Agency for Healthcare Research and Quality (US); 2013.

    Google Scholar 

  3. Zhang Z. Big data and clinical research: perspective from a clinician. J Thorac Dis. 2014;6:1659–64. https://doi.org/10.3978/j.issn.2072-1439.2014.12.12.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Gliklich REDN, Leavy MB. Registries for evaluating patient outcomes: a user’s guide. Rockville, MD: Agency for Healthcare Research and Quality (US); 2014.

    Google Scholar 

  5. Porta M. A dictionary of epidemiology. 5th ed. New York: Oxford University Press; 2008.

    Google Scholar 

  6. Vetter TR, Mascha EJ. Bias, confounding, and interaction: lions and tigers, and bears, oh my! Anesth Analg. 2017;125:1042–8. https://doi.org/10.1213/ANE.0000000000002332.

    Article  PubMed  Google Scholar 

  7. Rothman K. Epidemiology: an introduction. 2nd ed. New York: Oxford University Press; 2012.

    Google Scholar 

  8. Carlson MD, Morrison RS. Study design, precision, and validity in observational studies. J Palliat Med. 2009;12:77–82. https://doi.org/10.1089/jpm.2008.9690.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Norgaard M, Ehrenstein V, Vandenbroucke JP. Confounding in observational studies based on large health care databases: problems and potential solutions—a primer for the clinician. Clin Epidemiol. 2017;9:185–93. https://doi.org/10.2147/CLEP.S129879.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Cadilhac DA, Kim J, Lannin NA, et al. National stroke registries for monitoring and improving the quality of hospital care: a systematic review. Int J Stroke. 2016;11:28–40. https://doi.org/10.1177/1747493015607523.

    Article  PubMed  Google Scholar 

  11. American Heart Association. Get with the Guidelines®—stroke overview. 2020. https://www.heart.org/en/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/get-with-the-guidelines-stroke-overview. Accessed 30 Nov 2020.

  12. Xian Y, Liang L, Smith EE, et al. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA. 2012;307:2600–8. https://doi.org/10.1001/jama.2012.6756.

    Article  CAS  PubMed  Google Scholar 

  13. Asplund K, Hulter Asberg K, Norrving B, et al. Riks-stroke—a Swedish national quality register for stroke care. Cerebrovasc Dis. 2003;15(Suppl 1):5–7. https://doi.org/10.1159/000068203.

    Article  PubMed  Google Scholar 

  14. Michel P, Odier C, Rutgers M, et al. The Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging. Stroke. 2010;41:2491–8. https://doi.org/10.1161/STROKEAHA.110.596189.

    Article  PubMed  Google Scholar 

  15. Sato S, Sonoda K, Yoshimura S, Miyazaki Y, Matsuo R, Miura K, Imanaka Y, Isobe M, Saito Y, Kohro T, Nishimura K, Yasuda S, Ogawa H, Kitazono T, Iihara K, Minematsu K. Stroke registries in the world: a systematic review. Jpn J Stroke. 2018;40:331–42. https://doi.org/10.3995/jstroke.10587.

    Article  Google Scholar 

  16. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275–82. https://doi.org/10.1016/S0140-6736(07)60149-4.

    Article  CAS  PubMed  Google Scholar 

  17. Ahmed N, Wahlgren N, Grond M, et al. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol. 2010;9:866–74. https://doi.org/10.1016/S1474-4422(10)70165-4.

    Article  CAS  PubMed  Google Scholar 

  18. Wahlgren N, Ahmed N, Eriksson N, et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke. 2008;39:3316–22. https://doi.org/10.1161/STROKEAHA.107.510768.

    Article  PubMed  Google Scholar 

  19. Ford GA, Ahmed N, Azevedo E, et al. Intravenous alteplase for stroke in those older than 80 years old. Stroke. 2010;41:2568–74. https://doi.org/10.1161/STROKEAHA.110.581884.

    Article  PubMed  Google Scholar 

  20. Mishra NK, Ahmed N, Andersen G, et al. Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ. 2010;341:c6046. https://doi.org/10.1136/bmj.c6046.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Ahmed N, Lees KR, Ringleb PA, et al. Outcome after stroke thrombolysis in patients >80 years treated within 3 hours vs. >3–4.5 hours. Neurology. 2017;89:1561–8. https://doi.org/10.1212/WNL.0000000000004499.

    Article  PubMed  Google Scholar 

  22. Mishra NK, Davis SM, Kaste M, et al. Comparison of outcomes following thrombolytic therapy among patients with prior stroke and diabetes in the Virtual International Stroke Trials Archive (VISTA). Diabetes Care. 2010;33:2531–7. https://doi.org/10.2337/dc10-1125.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Karlinski M, Kobayashi A, Czlonkowska A, et al. Intravenous thrombolysis for stroke recurring within 3 months from the previous event. Stroke. 2015;46:3184–9. https://doi.org/10.1161/STROKEAHA.115.010420.

    Article  PubMed  Google Scholar 

  24. Mazya MV, Lees KR, Collas D, et al. IV thrombolysis in very severe and severe ischemic stroke: results from the SITS-ISTR registry. Neurology. 2015;85:2098–106. https://doi.org/10.1212/WNL.0000000000002199.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Mazya MV, Lees KR, Markus R, et al. Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin. Ann Neurol. 2013;74:266–74. https://doi.org/10.1002/ana.23924.

    Article  CAS  PubMed  Google Scholar 

  26. Tsivgoulis G, Katsanos AH, Mavridis D, et al. Intravenous thrombolysis for ischemic stroke patients on dual antiplatelets. Ann Neurol. 2018;84:89–97. https://doi.org/10.1002/ana.25269.

    Article  CAS  PubMed  Google Scholar 

  27. Cooray C, Mazya M, Mikulik R, et al. Safety and outcome of intravenous thrombolysis in stroke patients on prophylactic doses of low molecular weight heparins at stroke onset. Stroke. 2019;50:1149–55. https://doi.org/10.1161/STROKEAHA.118.024575.

    Article  CAS  PubMed  Google Scholar 

  28. Cooray C, Karlinski M, Kobayashi A, et al. Safety and early outcomes after intravenous thrombolysis in acute ischemic stroke patients with prestroke disability. Int J Stroke. 2020; https://doi.org/10.1177/1747493020954605.

  29. Mazya M, Egido JA, Ford GA, et al. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe implementation of treatments in stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke. 2012;43:1524–31. https://doi.org/10.1161/STROKEAHA.111.644815.

    Article  CAS  PubMed  Google Scholar 

  30. Toni D, Ahmed N, Anzini A, et al. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR. Neurology. 2012;78:880–7. https://doi.org/10.1212/WNL.0b013e31824d966b.

    Article  CAS  PubMed  Google Scholar 

  31. Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49:e46–e110. https://doi.org/10.1161/STR.0000000000000158.

    Article  PubMed  Google Scholar 

  32. Anani N, Mazya MV, Bill O, et al. Changes in European label and guideline adherence after updated recommendations for stroke thrombolysis: results from the safe implementation of treatments in stroke registry. Circ Cardiovasc Qual Outcomes. 2015;8:S155–62. https://doi.org/10.1161/CIRCOUTCOMES.115.002097.

    Article  PubMed  Google Scholar 

  33. Al-Rukn S, Mazya M, Akhtar N, et al. Stroke in the Middle East and North Africa: a 2-year prospective observational study of intravenous thrombolysis treatment in the region. Results from the SITS-MENA registry. Int J Stroke. 2019; https://doi.org/10.1177/1747493019874729.

  34. Rukn SA, Mazya MV, Hentati F, et al. Stroke in the Middle East and North Africa: a 2-year prospective observational study of stroke characteristics in the region—results from the safe implementation of treatments in stroke (SITS)—Middle East and North Africa (MENA). Int J Stroke. 2019;14:715–22. https://doi.org/10.1177/1747493019830331.

    Article  PubMed  Google Scholar 

  35. Alonso de Lecinana M, Mazya MV, Kostulas N, et al. Stroke care and application of thrombolysis in Ibero-America: report from the SITS-SIECV Ibero-American Stroke Register. Stroke. 2019;50:2507–12. https://doi.org/10.1161/STROKEAHA.119.025668.

    Article  PubMed  Google Scholar 

  36. Tsivgoulis G, Katsanos AH, Kadlecova P, et al. Intravenous thrombolysis for ischemic stroke in the golden hour: propensity-matched analysis from the SITS-EAST registry. J Neurol. 2017;264:912–20. https://doi.org/10.1007/s00415-017-8461-8.

    Article  PubMed  Google Scholar 

  37. Korv J, Vibo R, Kadlecova P, et al. Benefit of thrombolysis for stroke is maintained around the clock: results from the SITS-EAST registry. Eur J Neurol. 2014;21:112–7. https://doi.org/10.1111/ene.12257.

    Article  CAS  PubMed  Google Scholar 

  38. Anani N, Mazya MV, Chen R, et al. Applying openEHR’s Guideline Definition Language to the SITS international stroke treatment registry: a European retrospective observational study. BMC Med Inform Decis Mak. 2017;17:7. https://doi.org/10.1186/s12911-016-0401-5.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Xian Y, O’Brien EC, Fonarow GC, et al. Patient-centered research into outcomes stroke patients prefer and effectiveness research: implementing the patient-driven research paradigm to aid decision making in stroke care. Am Heart J. 2015;170:36–45, 45.e1–11. https://doi.org/10.1016/j.ahj.2015.04.008.

    Article  PubMed  Google Scholar 

  40. Ellis LE, Kass NE. Patient engagement in patient-centered outcomes research: challenges, facilitators and actions to strengthen the field. J Comp Eff Res. 2017;6:363–73. https://doi.org/10.2217/cer-2016-0075.

    Article  PubMed  Google Scholar 

  41. Rathert C, Wyrwich MD, Boren SA. Patient-centered care and outcomes: a systematic review of the literature. Med Care Res Rev. 2013;70:351–79. https://doi.org/10.1177/1077558712465774.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tiago Prazeres Moreira .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ahmed, N., Prazeres Moreira, T. (2021). Registry-Based Stroke Research. In: Fonseca, A.C., Ferro, J.M. (eds) Precision Medicine in Stroke. Springer, Cham. https://doi.org/10.1007/978-3-030-70761-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-70761-3_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-70760-6

  • Online ISBN: 978-3-030-70761-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics